INS and type 2 diabetes mellitus: A study revealed that, compared with that of needle-free insulin, the dosage of short-acting insulin was lower in hospitalized T2DM patients receiving intensive insulin therapy than in those receiving needle injection, but no difference was observed in long-acting insulin (23).